10.24335/L17404
RoyaltyStat
Asset purchase of all right, title and interest in patents, know-how, intellectual property, equipment, supplies, software, and materials related to imaging technology for the simultaneous visualization of spatial and temporal modulation of expression patterns of CRE, NFAT, NF-KB, AP-1, and c-fos transgenic reporter mice by bioluminescence or MRI; the gADME technology for screening compounds against panels of drug metabolizing enzymes; Transgenic Mice; the Additional Licensed Technology referred to as Pathfinder, Bromalytes, and Phenodetect; and the MC4 antagonist program to research, manufacture, use, and sell pharmaceutical products to diagnose, treat, and prevent diseases where the mode of action involves antagonism or melanocortin-4 receptor.
RoyaltyStat
2004